Apyx Medical Corporation Common Stock
Veridion Score
Composite trend over time
Why is APYX moving today?
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for APYX.
APYX insider activity
Apyx Medical Corporation Common Stock
No multi-insider buying cluster in the last 90 days
Net buying: $88K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-30 | Waldman Lawrence | Insider | sell | $4.49 | 5,024 | 12,314 | $23K | SEC Form 4 |
| 2026-07-02 | 2026-06-30 | Waldman Lawrence | Insider | buy | $1.88 | 12,000 | 17,338 | $23K | SEC Form 4 |
| 2026-03-17 | 2026-03-15 | CITRONOWICZ MOSHE | Insider | buy | $1.80 | 37,000 | 493,504 | $67K | SEC Form 4 |
| 2026-01-29 | 2026-01-27 | Roman Shawn David | Insider | buy | $1.80 | 12,000 | 12,000 | $22K | SEC Form 4 |
APYX contract awards, year to date.
Public federal awards linked to this ticker.
APYX lobbying filings, year to date.
Registered lobbying filings matched to Apyx Medical Corporation Common Stock.